Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond.

Saved in:
Bibliographic Details
Title: Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond.
Authors: Allahwala MA; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia., Marathe CS; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Endocrine and Metabolism Unit, Royal Adelaide Hospital, Adelaide, SA, Australia., Nelson AJ; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia., Psaltis PJ; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia., Marathe JA; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia. Electronic address: jessica.marathe@sahmri.com.
Source: Heart, lung & circulation [Heart Lung Circ] 2025 Oct; Vol. 34 (10), pp. 995-1005. Date of Electronic Publication: 2025 Sep 05.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Australia Country of Publication: Australia NLM ID: 100963739 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1444-2892 (Electronic) Linking ISSN: 14439506 NLM ISO Abbreviation: Heart Lung Circ Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1444-2892
DOI:10.1016/j.hlc.2025.07.005